Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A
Whereas the present results show that 6/32 cases were GLP1R positive, representing 18% of all our PanIN cases, it should be stressed that the 6 positive cases were all of the PanIN 1/2 type, and that the 12 cases with PanIN 3 were all negative
This GLP-1 intake form and eligibility workflow is built for medical weight loss clinics, med spas, and telehealth teams that need intake decisions to be fast, consistent, and clinically defensible
When you're working on your KLOW dosage guide, you need to be confident that the KLOW itself isn't introducing variability
Coverage is limited